Carmichael Times
Like Us On Facebook Follow Us On Twitter
Founded 1981
Serving Carmichael and Sacramento County
 
  Home Community Finance Employment Your Home Your Money Your Kids Your Health  
  Business Education Politics Police & Fire Veterans' News Real Estate Consumer News Taxes  
  Religion Food Recipes Gardening Car Care Fashion Beauty Pets  
  Lifestyles Sports Feature Writers Events Environment Human Interest Technology Travel  
 
50% of Hosting for your Website at GoDaddy.com! Local Classified Advertising
Pay Legal Ads Online
Messenger Publishing Group
Shop Local Carmichael Rewards Program
Constant Contact




Your Health

A New Approach To Treating Emphysema

Posted: 3/15/2013

It’s hoped a new treatment for advanced cases of emphysema can be an alternative to surgery
It’s hoped a new treatment for advanced cases of emphysema can be an alternative to surgery.

(NAPSI)—Those who have emphysema may soon be able to breathe a sigh of relief. That’s because alternative ways to treat advanced cases of the condition are being developed.

Emphysema is a progressive, debilitating lung condition affecting nearly 5 million people in the U.S. and 60 million people world- wide. It’s caused by irreversible damage to the delicate tissue of the lung that makes it difficult to breathe. The most commonly pre- scribed therapies for emphysema are bronchodilators (inhalers) and anti-inflammatory drugs, both of which are designed to relax and open the airways.

However, when medications fail to provide relief, emphysema patients have limited, highly invasive options: a major surgical procedure known as LVRS (Lung Volume Reduction Surgery) or a lung transplant. Both are high-risk and rarely performed.

An alternative treatment option that is approved in Europe is now being tested in a clinical trial in the United States. Called the AeriSeal System, manufactured by Aeris Therapeutics, it uses a specialized foam sealant to seal and shrink diseased areas of the lung. This is thought to be a less risky way to reduce lung volume without major surgery. Reducing lung volume leaves more space for healthier parts of the lung to function more effectively, making it easier to breathe. It’s believed this would improve quality of life for those living with more advanced emphysema.

The ASPIRE Clinical Study will involve approximately 300 patients at medical centers in the U.S., Israel and Europe.

To learn more, visit the website at www.ASPIREClinicalStudy.com.

Advertisers

left Pause Right
 

 




About The Carmichael Times | Copyright Notice
Carmichael Times| Paul V. Scholl, Publisher
P.O. Box 14 | Carmichael, CA 95609-0014 | Telephone: 916-773-1111 | Fax Line 916-773-2999
Email: publisher@MPG8.com | Site Designed and Hosted by TheSiteBarn.com
ISSN#: 1948-1918

Like Us On Facebook Follow Us On Twitter